Lana Medical Company (TADAWUL:9587)
Saudi Arabia
· Delayed Price · Currency is SAR
2.790
+0.040 (1.45%)
At close: Dec 4, 2025
Lana Medical Company Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 151 | 160 | 115 | - | - |
| Market Cap Growth | 17.89% | 38.75% | - | - | - |
| Enterprise Value | 160 | 165 | 120 | - | - |
| Last Close Price | 2.79 | 2.96 | 2.13 | - | - |
| PE Ratio | 12.09 | 12.83 | - | - | - |
| PS Ratio | 1.79 | 1.90 | 2.37 | - | - |
| PB Ratio | 2.47 | 2.62 | 2.36 | - | - |
| P/TBV Ratio | 2.48 | 2.63 | 2.37 | - | - |
| P/OCF Ratio | 383.16 | 406.51 | 112.52 | - | - |
| EV/Sales Ratio | 1.90 | 1.96 | 2.47 | - | - |
| EV/EBITDA Ratio | 9.22 | 14.74 | 107.83 | - | - |
| EV/EBIT Ratio | 11.54 | 19.44 | - | - | - |
| Debt / Equity Ratio | 0.25 | 0.25 | 0.23 | 0.16 | 0.21 |
| Debt / EBITDA Ratio | 1.29 | 1.29 | 7.11 | 0.94 | 1.04 |
| Debt / FCF Ratio | - | - | - | 15.15 | - |
| Asset Turnover | 0.94 | 0.94 | 0.70 | 0.68 | - |
| Inventory Turnover | 15.44 | 15.44 | 8.34 | 5.37 | - |
| Quick Ratio | 1.47 | 1.47 | 2.38 | 3.34 | 4.52 |
| Current Ratio | 1.87 | 1.87 | 3.03 | 4.16 | 5.39 |
| Return on Equity (ROE) | 22.70% | 22.70% | -4.00% | 12.34% | - |
| Return on Assets (ROA) | 5.92% | 5.92% | -0.33% | 6.77% | - |
| Return on Capital (ROIC) | 7.76% | 7.76% | -0.40% | 7.75% | - |
| Return on Capital Employed (ROCE) | 11.80% | 11.80% | -0.60% | 12.40% | 14.80% |
| Earnings Yield | 8.27% | 7.80% | -1.67% | - | - |
| FCF Yield | -2.47% | -2.33% | -2.11% | - | - |
| Buyback Yield / Dilution | - | -18.38% | -1.37% | -37.11% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.